DDAH2 is considered an antiatherosclerotic molecule: in fact, hypermethylation of DDAH2 promoter, accompanied by its reduced expression, correlates with endothelial dysfunction in patients affected by Coronary Artery Disease58. This evidence concerns the gene DDAH2 and endothelial dysfunction.